Morgan Stanley’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.4M | Buy |
|
|||||
|
2025
Q1 | $24.2M | Sell |
|
|||||
|
2024
Q4 | $56.4M | Sell |
|
|||||
|
2024
Q3 | $146M | Buy |
|
|||||
|
2024
Q2 | $112M | Buy |
|
|||||
|
2024
Q1 | $194M | Sell |
|
|||||
|
2023
Q4 | $468M | Buy |
|
|||||
|
2023
Q3 | $179M | Sell |
|
|||||
|
2023
Q2 | $315M | Sell |
|
|||||
|
2023
Q1 | $587M | Buy |
|
|||||
|
2022
Q4 | $376M | Sell |
|
|||||
|
2022
Q3 | $297M | Buy |
|
|||||
|
2022
Q2 | $403M | Sell |
|
|||||
|
2022
Q1 | $708M | Buy |
|
|||||
|
2021
Q4 | $724M | Sell |
|
|||||
|
2021
Q3 | $884M | Buy |
|
|||||
|
2021
Q2 | $847M | Buy |
|
|||||
|
2021
Q1 | $749M | Sell |
|
|||||
|
2020
Q4 | $950M | Sell |
|
|||||
|
2020
Q3 | $1.21B | Buy |
|
|||||
|
2020
Q2 | $734M | Buy |
|
|||||
|
2020
Q1 | $315M | Buy |
|
|||||
|
2019
Q4 | $83.1M | Buy |
|
|||||
|
2019
Q3 | $23M | Buy |
|